Akhavan P - Search Results

1

Canadian Rheumatology Association Living Guidelines for Rheumatoid Arthritis: Update #1.

Hazlewood GS, Akhavan P, Pardo JP, Agarwal A, Schieir O, Barber CEH, Proulx L, Richards DP, Bombardier C, Pope JE, Barnabe C, Tugwell P, Jamal S, Thorne JC, Nikolic RPA, Khraishi M, Bansback N, Legge A, Bykerk V, Taylor-Gjevre R. Hazlewood GS, et al. Among authors: akhavan p. J Rheumatol. 2023 Sep;50(9):1198-1199. doi: 10.3899/jrheum.2023-0625. Epub 2023 Aug 1. J Rheumatol. 2023. PMID: 37527865 No abstract available.

2

Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.

Akhavan PS, Movahedi M, Cesta A, Bombardier C; and other OBRI investigators. Akhavan PS, et al. Clin Exp Rheumatol. 2023 Nov;41(11):2249-2256. doi: 10.55563/clinexprheumatol/r7b8go. Epub 2023 Jun 15. Clin Exp Rheumatol. 2023. PMID: 37382462

3

Canadian Rheumatology Association Living Guidelines for the Pharmacological Management of Rheumatoid Arthritis With Disease-Modifying Antirheumatic Drugs.

Hazlewood GS, Pardo JP, Barnabe C, Schieir O, Barber CEH, Proulx L, Richards DP, Tugwell P, Bansback N, Akhavan P, Bombardier C, Bykerk V, Jamal S, Khraishi M, Taylor-Gjevre R, Thorne JC, Agarwal A, Pope JE. Hazlewood GS, et al. Among authors: akhavan p. J Rheumatol. 2022 Oct;49(10):1092-1099. doi: 10.3899/jrheum.220209. Epub 2022 Jul 15. J Rheumatol. 2022. PMID: 35840155 Free article.

4

Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous.

Moazzami M, Katz P, Bonilla D, Engel L, Su J, Akhavan P, Anderson N, Tayer-Shifman OE, Beaton D, Touma Z. Moazzami M, et al. Among authors: akhavan p. Lupus. 2021 Nov;30(13):2102-2113. doi: 10.1177/09612033211051275. Epub 2021 Nov 19. Lupus. 2021. PMID: 34797991 Free PMC article.

5

IoT-Blockchain: Harnessing the Power of Internet of Thing and Blockchain for Smart Supply Chain.

Azizi N, Malekzadeh H, Akhavan P, Haass O, Saremi S, Mirjalili S. Azizi N, et al. Among authors: akhavan p. Sensors (Basel). 2021 Sep 9;21(18):6048. doi: 10.3390/s21186048. Sensors (Basel). 2021. PMID: 34577261 Free PMC article.

6

Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.

Hazlewood GS, Bombardier C, Li X, Movahedi M, Choquette D, Coupal L, Bykerk VP, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH; OBRI, RHUMADATA, CATCH Investigators, and the Rheum4U Team. Hazlewood GS, et al. J Rheumatol. 2022 Jan;49(1):16-25. doi: 10.3899/jrheum.201688. Epub 2021 Aug 1. J Rheumatol. 2022. PMID: 34334357

7

Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada.

Barber CEH, Then KL, Bohm V, Hall M, Marshall DA, Rankin JA, Barnabe C, Hazlewood GS, Li LC, Mosher D, Homik J, MacMullan P, Tsui K, English K, Lacaille D; Kelly English, and Diane Lacaille for the RA Quality Measurement Delphi Panel Group. Barber CEH, et al. J Rheumatol. 2021 Mar;48(3):326-334. doi: 10.3899/jrheum.200688. Epub 2020 Sep 1. J Rheumatol. 2021. PMID: 33452175

8

Modified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid Arthritis.

Movahedi M, Weber D, Akhavan P, Keystone EC. Movahedi M, et al. Among authors: akhavan p. ACR Open Rheumatol. 2020 Mar;2(3):188-194. doi: 10.1002/acr2.11123. Epub 2020 Mar 14. ACR Open Rheumatol. 2020. PMID: 32170838 Free PMC article.

9

Collection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative-a rheumatoid arthritis cohort.

Movahedi M, Cesta A, Li X, Bombardier C; OBRI Investigators. Movahedi M, et al. J Clin Epidemiol. 2019 Oct;114:95-103. doi: 10.1016/j.jclinepi.2019.06.012. Epub 2019 Jun 18. J Clin Epidemiol. 2019. PMID: 31226411

10

Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results.

Lau AN, Thorne JC, Movahedi M, Rampakakis E, Cesta A, Li X, Couto S, Sampalis J, Bombardier C; OBRI Investigators. Lau AN, et al. J Rheumatol. 2019 Aug;46(8):874-886. doi: 10.3899/jrheum.180486. Epub 2019 Apr 15. J Rheumatol. 2019. PMID: 30988121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page